What Endiya Partners does

Endiya Partners is a Hyderabad-headquartered early-stage venture capital firm founded in 2015–2016 (firmographics list 2015; legal records reference 2016) by Sateesh Andra and Dr. Ramesh Byrapaneni. The firm operates as a "co-founder VC," writing first institutional cheques of up to USD 2 million at seed and pre-Series A for startups in AI, Deep Tech, and Healthcare. Investment is organized around four verticals — Enterprise Technology (AI, Data, Cyber Security), Industrial Tech & Intelligent Mobility (Edge AI, Robotics, Fabless Semiconductors), Healthcare & Lifesciences (Digital Health, Biotech, Medical Devices), and Fintech (Digital Lending, Alternate Investments, Equity Management) — with active deal sourcing concentrated in referrals from portfolio founders, co-investors, and Endiya alums.

The firm's revenue model follows standard VC mechanics: management fees on committed capital and carried interest (typically ~20%) on fund profits. Endiya has raised three funds, with Fund III closed in 2025 at ₹800 crore (~USD 95 million) targeting deep-tech, healthcare, and enterprise software. Approximately 15% of Fund III was deployed at announcement, with plans to back 17–18 startups over 18 months. Operations are split between the Hyderabad headquarters (Phoenix Primea, Financial District) and a Cupertino, California office, supporting cross-border deal flow between India and Silicon Valley. A small 1–10 person investment team runs the firm.

The portfolio includes breakout outcomes: Darwinbox (HR-tech unicorn, ~USD 1.2B valuation), Kissht (digital lending platform, IPO on BSE/NSE in May 2026), SigTuple (FDA-approved AI digital microscopy), Eyestem (cell therapy in CDSCO Phase 2), plus active SaaS and deep-tech positions in Scrut Automation, Matters.AI, Zluri, Qapita, AquaExchange, Sugar.Fit, OpenCFO, ThirdAI, Perceptyne Robots, and BluJ Aerospace. Fund I delivered a 2.0x distributed-to-paid-in ratio prior to the Kissht IPO, and portfolio companies have collectively raised 25x initial invested capital in follow-on funding, indicating broad downstream market validation.

Name

Endiya Partners

Legal name

Endiya Fund Advisors Pvt Ltd

Website

https://endiya.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Short description

Endiya Partners is a Hyderabad-based early-stage venture capital firm writing first cheques of up to USD 2 million for AI, Deep Tech, and Healthcare startups across India and Silicon Valley, with three active funds and a portfolio including unicorns and IPO-stage companies.

Ownership category

akta.pro rank

Product category

Early-Stage Venture Capital

NAICS

Portfolio Management and Investment Advice (523940)

SIC

Investment Advice (6282)

akta.pro primary industry

Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

Keywords

• Early-stage venture capital
• Seed-stage startup funding
• Deep tech investments
• Healthcare venture investing
• Startup equity financing

Headquarters

HQ city

Hyderabad

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Management Fees and Carried Interest: As a venture capital firm, Endiya Partners generates returns through management fees on committed capital and carried interest (typically 20%) on fund profits. Their Fund III is a ₹800 crore vehicle focused on deep-tech, healthcare, and enterprise software sectors.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Endiya Partners is an early-stage venture capital firm that invests in AI, Deep Tech, and Healthcare startups at seed and pre-Series A stages. The firm writes first institutional cheques up to $2 million and provides ongoing strategic guidance, network access, and follow-on capital to portfolio companies. The firm manages multiple funds, including a ₹800 crore Fund III focused on deep-tech, healthcare, and enterprise software sectors.

Product overview

Endiya Partners is a Hyderabad-based early-stage venture capital firm operating as a co-founder VC for startups in AI, Deep Tech, and Healthcare. As a VC firm, it does not itself sell a unified product platform, but rather provides investment capital, operational expertise, and strategic guidance to early-stage companies. Its portfolio includes multiple product companies spanning distinct verticals: SigTuple offers AI-led digital microscopy; Eyestem develops stem cell therapies; Scrut Automation provides GRC automation; Qapita operates an equity management SaaS platform; Darwinbox delivers a cloud-native HRMS; Sugar.Fit addresses chronic disease management; Zluri offers identity governance and SaaS management; AquaExchange delivers an integrated aquaculture technology platform; and Kissht provides a digital lending platform. The firm also publishes industry reports through its DEMO initiative covering semiconductors and biopharma.

Differentiator

Problem solved

Functional benefit

Products and services

• Endiya Fund III An ₹800 crore early-stage venture capital fund focused on deep-tech, healthcare, and enterprise software sectors. The fund writes first cheques up to $2 million for seed and pre-Series A startups in AI, Industrial Tech, Healthcare, and Fintech.
• Early-Stage Seed Investment Program First institutional seed investment program providing capital up to $2 million for seed and pre-Series A startups in AI, Deep Tech, Healthcare, Fintech, and Industrial Tech sectors, combined with operator-style strategic guidance, technology reviews, GTM strategy support, and follow-on capital commitments.

Quantifiable outcome

• 25x capital raised by portfolio companies from initial investment
• +1 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• pi Ventures: India-based early-stage VC specializing in AI, ML, and deep-tech startups. Co-invested with Endiya in Pandorum Technologies; similar seed-to-Series A focus on frontier tech from India.
• 3one4 Capital: Early-stage Indian VC backing tech-led product companies. Co-invested with Endiya in Pandorum Technologies and shares a comparable stage and product-company orientation.
• Kalaari Capital: Indian early-stage venture capital firm focused on technology and deep-tech startups. Co-led Matters.AI seed with Endiya Partners, directly comparable in stage, sector focus, and India-first thesis.
• Blume Ventures: One of India's most active seed and early-stage venture funds covering enterprise, consumer, and deep tech. Closely comparable to Endiya in seed-first, India-focused investing and follow-on support.
• Vertex Ventures: Southeast Asia and India-focused early-stage VC. Co-invested with Endiya in Kissht; comparable stage and India-region mandate with similar sector breadth.
• Capria Ventures: Emerging-markets-focused early-stage VC. Co-led ThirdAI Automation seed with Endiya Partners; comparable stage and emerging-market deep-tech orientation.
• Sorin Investments: India-focused early-stage VC investing across consumer, fintech, and healthcare. Co-invested with Endiya in Nivaan Care, mirroring its sector-spanning early-stage thesis.

Broad incumbents

• Accel India: Large global VC with major India franchise backing early and growth-stage tech companies. Operates at broader scale than Endiya but competes for the same early-stage Indian tech deals.

Emerging players

• Stride Ventures: India-focused growth and venture debt provider. Led Pandorum Technologies Series B with Endiya participating; comparable India focus but debt-led model differs from Endiya's pure equity approach.
• W Health Ventures: Healthcare-focused early-stage investor in India. Co-invested with Endiya in Nivaan Care; comparable stage with narrower healthcare-only mandate.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/endiyavc
• Facebookfacebook.com/endiyapartners
• LinkedInlinkedin.com/company/endiya-partners
• Instagraminstagram.com/endiyavc

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments89 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Endiya Partners